Article

Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction

2024-06-03

Abstract excerpt

Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20-30% showing de novo resistance to platinum-based chemotherapy. While hematoxylin-eosin (H&E) pathological slides are used for routine diagnosis of cancer type, they may also contain diagnostically useful information about treatment response. Our study demonstrates that combining H&E-stained Whole Slide Images (WSI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bb178e12-5dff-5e81-a7df-32e613cb870e
DOI: 10.1101/2024.06.01.24308293

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response predictionDOI 10.1101/2024.06.01.24308293Read

Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response predictionSemantic proximity Read

HRDPath: An Explainable Multi-Model Deep Learning Architecture for Predicting Homologous Recombination Deficiency from Histopathology ImagesSemantic proximity Read

Homologous recombination deficiency prediction from whole slide images using label refinement and foundation-model benchmarking in ovarian cancerSemantic proximity Read

Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancerSemantic proximity Read

AI-Enabled Prediction of Homologous Recombination Deficiency from Histopathology ImagesSemantic proximity Read

Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide imagesSemantic proximity Read

Homologous Recombination Deficiency in Ovarian and Breast Cancers: Biomarkers, Diagnosis, and TreatmentSemantic proximity Read

High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions.Semantic proximity Read

IdentifiHR: predicting homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expressionSemantic proximity Read

Proteomic landscape of epithelial ovarian cancer.Semantic proximity Read

The utility of homologous recombination deficiency biomarkers across cancer typesSemantic proximity Read

Coordinated protein modules define DNA damage responses to carboplatin at single cell resolution in human ovarian carcinoma modelsSemantic proximity Read